Skip to main content

Table 4 Clinical Characteristics and therapy according to stroke subtypes

From: Immediate and one-year outcome of patients presenting with Acute Coronary Syndrome complicated by stroke: Findings from the 2ndGulf Registry of Acute Coronary Events (Gulf RACE-2)

  Ischemic Hemorrhagic Not identified P-value
No (%) 29(52%) 19 (34%) 8(14%)  
Age 60.5 ± 12 60 ± 11 67 ± 15 0.41
Gender Female 10(34.5) 2(10.5) 2(25) 0.17
Diabetes Mellitus 16(52.2) 7(36.8) 1(12.5) 0.08
Hypertension 20(69) 9(47.4) 6(75) 0.23
Atrial fibrillation 4(13.8) 0(0) 0(0) 0.14
Heart rate 92 ± 19 89.9 ± 15 83 ± 30 0.54
Systolic blood pressure 132 ± 30 139 ± 35 116 ± 50 0.29
Diastolic blood pressure 76 ± 24 84 ± 19 68 ± 32 0.28
STEMI 20(69) 16(84.2) 4(50)  
NSTEMI 6(20.7) 1(5.3) 3(37.5)  
UA 3(0.3) 2(10.5) 1(12.5) 0.34
Coronary Angiogram 5(17.2) 1(5.3) 1(12.5) 0.30
PCI 2(6.9) 1(5.3) 0(0) 0.47
Medications on admission     
Thrombolytic therapy 10(52.6) 5(31.2) 0(0) 0.11
Glycoprotein IIb/III inhibitors 12(41.4) 7(36.8) 6(75) 0.17
aspirin 26(89.7) 17(89.5) 8(100) 0.63
Clopidogrel 15(51.7) 6(31.6) 4(50) 0.37